← Every applicant

Alkem Labs Ltd FDA Approvals

68 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product
SOLRIAMFETOL HYDROCHLORIDENew drugJun 17, 2026TABLET, ORAL
TOLVAPTANNew drugApr 21, 2026TABLET, ORAL
DAPAGLIFLOZINNew drugApr 6, 2026TABLET, ORAL
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDENew drugApr 6, 2026TABLET, EXTENDED RELEASE, ORAL
BRIVARACETAMNew drugFeb 23, 2026SOLUTION, ORAL
MIRABEGRONNew drugJan 20, 2026FOR SUSPENSION, EXTENDED RELEASE, ORAL
TICAGRELORNew drugOct 28, 2025TABLET, ORAL
LIDOCAINENew drugOct 6, 2025PATCH, TOPICAL
RIVAROXABANNew drugJun 26, 2025FOR SUSPENSION, ORAL
PRUCALOPRIDE SUCCINATENew drugJun 24, 2025TABLET, ORAL
LANTHANUM CARBONATENew drugMar 13, 2025TABLET, CHEWABLE, ORAL
NIMODIPINENew drugJan 22, 2025SOLUTION, ORAL
AZILSARTAN MEDOXOMIL AND CHLORTHALIDONENew drugJan 21, 2025TABLET, ORAL
CARBAMAZEPINENew drugJan 14, 2025TABLET, EXTENDED RELEASE, ORAL
TOPIRAMATENew drugOct 31, 2024SOLUTION, ORAL
CEPHALEXINNew drugSep 27, 2024TABLET, ORAL
SACUBITRIL AND VALSARTANNew drugSep 16, 2024TABLET, ORAL
RILUZOLENew drugAug 22, 2024SUSPENSION, ORAL
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDENew drugJul 11, 2024TABLET, ORAL
TOPIRAMATENew drugJun 13, 2024CAPSULE, ORAL
CEFPROZILNew drugApr 9, 2024TABLET, ORAL
OXCARBAZEPINENew drugMar 18, 2024SUSPENSION, ORAL
MIRABEGRONNew drugFeb 12, 2024TABLET, EXTENDED RELEASE, ORAL
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATENew drugDec 29, 2023SOLUTION, ORAL
CLOPIDOGREL BISULFATENew drugDec 8, 2023TABLET, ORAL
BREXPIPRAZOLENew drugNov 28, 2023TABLET, ORAL
ESLICARBAZEPINE ACETATENew drugOct 6, 2023TABLET, ORAL
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATENew drugOct 6, 2023TABLET, ORAL
LISDEXAMFETAMINE DIMESYLATENew drugAug 25, 2023CAPSULE, ORAL
TEMAZEPAMNew drugAug 24, 2023CAPSULE, ORAL
VARENICLINE TARTRATENew drugAug 23, 2023TABLET, ORAL
TOPIRAMATENew drugJun 20, 2023CAPSULE, EXTENDED RELEASE, ORAL
METHYLPHENIDATE HYDROCHLORIDENew drugMay 23, 2023TABLET, EXTENDED RELEASE, ORAL
FAMOTIDINENew drugMay 15, 2023FOR SUSPENSION, ORAL
FAMOTIDINENew drugApr 24, 2023TABLET, ORAL
TICAGRELORNew drugApr 21, 2023TABLET, ORAL
ROFLUMILASTNew drugApr 18, 2023TABLET, ORAL
LURASIDONE HYDROCHLORIDENew drugDec 13, 2022TABLET, ORAL
VANCOMYCIN HYDROCHLORIDENew drugNov 14, 2022FOR SOLUTION, ORAL
DICLOFENAC POTASSIUMNew drugJul 20, 2022FOR SOLUTION, ORAL
ERYTHROMYCINNew drugJul 13, 2022TABLET, ORAL
LEVETIRACETAMNew drugMay 27, 2022TABLET, ORAL
LACOSAMIDENew drugMay 19, 2022SOLUTION, ORAL
CEFPODOXIME PROXETILNew drugMay 18, 2022TABLET, ORAL
LACOSAMIDENew drugMar 31, 2022TABLET, ORAL
ENALAPRIL MALEATENew drugMar 30, 2022SOLUTION, ORAL
NIFEDIPINENew drugMar 29, 2022TABLET, EXTENDED RELEASE, ORAL
FEBUXOSTATNew drugDec 7, 2021TABLET, ORAL
EVEROLIMUSNew drugNov 26, 2021TABLET, ORAL
FOSFOMYCIN TROMETHAMINENew drugOct 21, 2021FOR SOLUTION, ORAL
CHOLESTYRAMINENew drugOct 19, 2021POWDER, ORAL
CHOLESTYRAMINE LIGHTNew drugOct 19, 2021POWDER, ORAL
MYCOPHENOLATE SODIUMNew drugSep 23, 2021TABLET, DELAYED RELEASE, ORAL
APREMILASTNew drugSep 21, 2021TABLET, ORAL
IBUPROFENNew drugSep 13, 2021TABLET, ORAL
IBUPROFEN AND FAMOTIDINENew drugAug 3, 2021TABLET, ORAL
MESALAMINENew drugJul 15, 2021CAPSULE, EXTENDED RELEASE, ORAL
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDENew drugJun 15, 2021TABLET, SUBLINGUAL
VENLAFAXINE HYDROCHLORIDENew drugJun 10, 2021TABLET, EXTENDED RELEASE, ORAL
CLOBAZAMNew drugMay 6, 2021SUSPENSION, ORAL
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDENew drugApr 26, 2021CAPSULE, ORAL
TOBRAMYCINNew drugApr 1, 2021SOLUTION, INHALATION
SIROLIMUSNew drugMar 12, 2021TABLET, ORAL
RUFINAMIDENew drugFeb 23, 2021SUSPENSION, ORAL
CEFIXIMENew drugFeb 19, 2021FOR SUSPENSION, ORAL
CEFDINIRNew drugFeb 19, 2021FOR SUSPENSION, ORAL
CEFDINIRNew drugFeb 19, 2021CAPSULE, ORAL
DROXIDOPANew drugFeb 18, 2021CAPSULE, ORAL

Related datasets